Last updated on April 2020

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Brief description of study

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.

Clinical Study Identifier: NCT03872401

Find a site near you

Start Over

Research Site

Moron, Argentina
  Connect »